Mayne Pharma (ASX:MYX) posts another half-yearly loss, hits seven-year low
- ASX 200 pharmaceutical company Mayne Pharma (MYX) has posted a $17.5 million loss in its latest half-yearly report
- Fierce overseas competition drove revenue, earnings, and profits down for the company compared to the same time the year before
- However, with some severe business restructuring, today's loss is not as heavy as January to June 2019
Mayne Pharma (ASX:MYX) posts another half-yearly loss, hits...
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.64 |
Change
0.160(3.57%) |
Mkt cap ! $393.0M | |||
| Open | High | Low | Value | Volume |
| $4.50 | $4.66 | $4.47 | $499.3K | 108.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 1038 | $4.64 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.65 | 4117 | 5 |
View Market Depth
| Last trade - 12.02pm 14/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$4.62 |
Change
0.160 ( 2.63 %) |
||||
| Open | High | Low | Volume | ||
| $4.47 | $4.67 | $4.47 | 19767 | ||
| Last updated 12.21pm 14/06/2024 ? | |||||
| MYX (ASX) Chart |